Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TCMD |
---|---|---|
09:32 ET | 530 | 13.085 |
09:42 ET | 300 | 12.965 |
09:44 ET | 2894 | 12.83 |
09:48 ET | 4000 | 12.9 |
09:50 ET | 200 | 12.925 |
09:51 ET | 1000 | 12.95 |
09:53 ET | 1607 | 13.02 |
09:55 ET | 1700 | 13.01 |
09:57 ET | 400 | 12.98 |
10:00 ET | 200 | 13 |
10:02 ET | 200 | 12.97 |
10:04 ET | 900 | 12.94 |
10:06 ET | 400 | 12.92 |
10:08 ET | 100 | 12.9 |
10:09 ET | 600 | 12.95 |
10:11 ET | 700 | 12.98 |
10:13 ET | 1000 | 12.93 |
10:18 ET | 200 | 12.97 |
10:20 ET | 1500 | 13.0001 |
10:24 ET | 600 | 13.015 |
10:26 ET | 100 | 13.01 |
10:27 ET | 100 | 13 |
10:29 ET | 1690 | 12.99 |
10:38 ET | 500 | 13.035 |
10:40 ET | 500 | 13.03 |
10:42 ET | 600 | 13.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Tactile Systems Technology Inc | 257.8M | -8.6x | --- |
GeneDx Holdings Corp | 155.4M | -0.5x | --- |
Fujifilm Holdings Corp | 27.3B | 13.1x | +12.26% |
OraSure Technologies Inc | 387.1M | -9.0x | --- |
InfuSystem Holdings Inc | 201.6M | 794.1x | --- |
Semler Scientific Inc | 247.9M | 23.3x | --- |
Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $257.8M |
---|---|
Revenue (TTM) | $234.6M |
Shares Outstanding | 20.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.20 |
EPS | $-1.50 |
Book Value | $6.45 |
P/E Ratio | -8.6x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -7.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.